Allyn C. Howlett - Publications

Affiliations: 
Saint Louis University, St. Louis, MO, United States 
Area:
Pharmacology, Neuroscience Biology

139 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Eldeeb K, Leone-Kabler S, Howlett AC. Mouse Neuroblastoma CB1 Cannabinoid Receptor-Stimulated [(35)S]GTPɣS Binding: Total and Antibody-Targeted Gα Protein-Specific Scintillation Proximity Assays. Methods in Enzymology. 593: 1-21. PMID 28750799 DOI: 10.1016/bs.mie.2017.06.028  0.32
2016 Budygin EA, Oleson EB, Lee YB, Blume LC, Bruno MJ, Howlett AC, Thompson AC, Bass CE. Acute Depletion of D2 Receptors from the Rat Substantia Nigra Alters Dopamine Kinetics in the Dorsal Striatum and Drug Responsivity. Frontiers in Behavioral Neuroscience. 10: 248. PMID 28154530 DOI: 10.3389/fnbeh.2016.00248  0.36
2016 Blume LC, Patten T, Eldeeb K, Leone-Kabler S, Ilyasov AA, Keegan BM, O'Neal JE, Bass CE, Hantgan RR, Lowther WT, Selley DE, Howlett AC. Cannabinoid Receptor Interacting Protein (CRIP) 1a competition with β-arrestin for CB1 receptor binding sites. Molecular Pharmacology. PMID 27895162 DOI: 10.1124/mol.116.104638  0.36
2016 Luessen DJ, Hinshaw TP, Sun H, Howlett AC, Marrs G, McCool BA, Chen R. RGS2 modulates the activity and internalization of dopamine D2 receptors in neuroblastoma N2A cells. Neuropharmacology. PMID 27528587 DOI: 10.1016/j.neuropharm.2016.08.009  0.32
2016 Blume LC, Leone-Kabler S, Luessen DJ, Marrs GS, Lyons E, Bass CE, Chen R, Selley DE, Howlett AC. Cannabinoid Receptor Interacting Protein (CRIP1a) suppresses agonist-driven CB1 receptor internalization, and regulates receptor replenishment in an agonist-biased manner. Journal of Neurochemistry. PMID 27513693 DOI: 10.1111/jnc.13767  0.36
2016 Eldeeb K, Leone-Kabler S, Howlett AC. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function. Journal of Basic and Clinical Physiology and Pharmacology. 27: 311-22. PMID 27089415 DOI: 10.1515/jbcpp-2015-0096  1
2015 Sesay JS, Gyapong RN, Najafi LT, Kabler SL, Diz DI, Howlett AC, Awumey EM. Gαi/o-dependent Ca(2+) mobilization and Gαq-dependent PKCα regulation of Ca(2+)-sensing receptor-mediated responses in N18TG2 neuroblastoma cells. Neurochemistry International. 90: 142-51. PMID 26190181 DOI: 10.1016/j.neuint.2015.07.008  1
2015 Keegan BM, Beveridge TJ, Pezor JJ, Xiao R, Sexton T, Childers SR, Howlett AC. Chronic baclofen desensitizes GABAB-mediated G-protein activation and stimulates phosphorylation of kinases in mesocorticolimbic rat brain. Neuropharmacology. 95: 492-502. PMID 25724082 DOI: 10.1016/j.neuropharm.2015.02.021  1
2015 Smith TH, Blume LC, Straiker A, Cox JO, David BG, McVoy JR, Sayers KW, Poklis JL, Abdullah RA, Egertová M, Chen CK, Mackie K, Elphick MR, Howlett AC, Selley DE. Cannabinoid receptor-interacting protein 1a modulates CB1 receptor signaling and regulation. Molecular Pharmacology. 87: 747-65. PMID 25657338 DOI: 10.1124/mol.114.096495  0.36
2015 Blume LC, Eldeeb K, Bass CE, Selley DE, Howlett AC. Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells. Cellular Signalling. 27: 716-26. PMID 25446256 DOI: 10.1016/j.cellsig.2014.11.006  1
2014 Mechoulam R, Hanuš LO, Pertwee R, Howlett AC. Early phytocannabinoid chemistry to endocannabinoids and beyond Nature Reviews Neuroscience. 15: 757-764. PMID 25315390 DOI: 10.1038/nrn3811  1
2014 Pulgar VM, Yamaleyeva LM, Varagic J, McGee CM, Bader M, Dechend R, Howlett AC, Brosnihan KB. Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis. Hypertension. 64: 619-25. PMID 24935942 DOI: 10.1161/HYPERTENSIONAHA.114.03633  1
2014 Malpass GE, Arimilli S, Prasad GL, Howlett AC. Regulation of gene expression by tobacco product preparations in cultured human dermal fibroblasts. Toxicology and Applied Pharmacology. 279: 211-9. PMID 24927667 DOI: 10.1016/j.taap.2014.06.001  1
2014 Calipari ES, Sun H, Eldeeb K, Luessen DJ, Feng X, Howlett AC, Jones SR, Chen R. Amphetamine self-administration attenuates dopamine D2 autoreceptor function. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1833-42. PMID 24513972 DOI: 10.1038/npp.2014.30  1
2014 Campeau L, Füllhase C, Sawada N, Gratzke C, Hedlund P, Howlett AC, Andersson KE. Characterization of bladder function in a cannabinoid receptor type 2 knockout mouse in vivo and in vitro. Neurourology and Urodynamics. 33: 566-70. PMID 23908133 DOI: 10.1002/nau.22454  1
2014 Blume LC, Eldeeb KM, Howlett AC. Cannabinoid receptor intracellular signalling: The long journey from binding sites to biological effects Cannabinoids. 17-52. DOI: 10.1002/9781118451281.ch2  1
2013 Thomas G, Betters JL, Lord CC, Brown AL, Marshall S, Ferguson D, Sawyer J, Davis MA, Melchior JT, Blume LC, Howlett AC, Ivanova PT, Milne SB, Myers DS, Mrak I, et al. The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome. Cell Reports. 5: 508-20. PMID 24095738 DOI: 10.1016/j.celrep.2013.08.047  1
2013 Malpass GE, Arimilli S, Prasad GL, Howlett AC. Complete artificial saliva alters expression of proinflammatory cytokines in human dermal fibroblasts. Toxicological Sciences : An Official Journal of the Society of Toxicology. 134: 18-25. PMID 23629517 DOI: 10.1093/toxsci/kft103  1
2013 Dalton GD, Peterson LJ, Howlett AC. CB₁ cannabinoid receptors promote maximal FAK catalytic activity by stimulating cooperative signaling between receptor tyrosine kinases and integrins in neuronal cells. Cellular Signalling. 25: 1665-77. PMID 23571270 DOI: 10.1016/j.cellsig.2013.03.020  1
2013 McQuail JA, Davis KN, Miller F, Hampson RE, Deadwyler SA, Howlett AC, Nicolle MM. Hippocampal Gαq/₁₁ but not Gαo-coupled receptors are altered in aging. Neuropharmacology. 70: 63-73. PMID 23347951 DOI: 10.1016/j.neuropharm.2013.01.009  1
2013 Blume LC, Bass CE, Childers SR, Dalton GD, Roberts DC, Richardson JM, Xiao R, Selley DE, Howlett AC. Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and δ opioid systems. Journal of Neurochemistry. 124: 808-20. PMID 23286559 DOI: 10.1111/jnc.12139  1
2012 Oddi S, Dainese E, Sandiford S, Fezza F, Lanuti M, Chiurchiù V, Totaro A, Catanzaro G, Barcaroli D, De Laurenzi V, Centonze D, Mukhopadhyay S, Selent J, Howlett AC, Maccarrone M. Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling. British Journal of Pharmacology. 165: 2635-51. PMID 21895628 DOI: 10.1111/j.1476-5381.2011.01658.x  1
2012 Dalton GD, Howlett AC. Cannabinoid CB1 receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells. British Journal of Pharmacology. 165: 2497-511. PMID 21518335 DOI: 10.1111/j.1476-5381.2011.01455.x  1
2011 Howlett AC, Reggio PH, Childers SR, Hampson RE, Ulloa NM, Deutsch DG. Endocannabinoid tone versus constitutive activity of cannabinoid receptors. British Journal of Pharmacology. 163: 1329-43. PMID 21545414 DOI: 10.1111/j.1476-5381.2011.01364.x  1
2011 Shohami E, Cohen-Yeshurun A, Magid L, Algali M, Mechoulam R. Endocannabinoids and traumatic brain injury British Journal of Pharmacology. 163: 1402-1410. DOI: 10.1111/bph.2011.163  1
2010 Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K, Mechoulam R, Ross RA. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CBâ‚‚. Pharmacological Reviews. 62: 588-631. PMID 21079038 DOI: 10.1124/pr.110.003004  1
2010 Skelly MJ, Guy EG, Howlett AC, Pratt WE. CB1 receptors modulate the intake of a sweetened-fat diet in response to μ-opioid receptor stimulation of the nucleus accumbens. Pharmacology, Biochemistry, and Behavior. 97: 144-51. PMID 20562021 DOI: 10.1016/j.pbb.2010.05.024  1
2010 Howlett AC, Blume LC, Dalton GD. CB(1) cannabinoid receptors and their associated proteins. Current Medicinal Chemistry. 17: 1382-93. PMID 20166926 DOI: 10.2174/092986710790980023  1
2009 Dalton GD, Bass CE, Van Horn CG, Howlett AC. Signal transduction via cannabinoid receptors. Cns & Neurological Disorders Drug Targets. 8: 422-31. PMID 19839935 DOI: 10.2174/187152709789824615  1
2009 Carney ST, Lloyd ML, MacKinnon SE, Newton DC, Jones JD, Howlett AC, Norford DC. Cannabinoid regulation of nitric oxide synthase I (nNOS) in neuronal cells. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 4: 338-49. PMID 19365734 DOI: 10.1007/s11481-009-9153-7  1
2008 Gerald TM, Howlett AC, Ward GR, Ho C, Franklin SO. Gene expression of opioid and dopamine systems in mouse striatum: effects of CB1 receptors, age and sex. Psychopharmacology. 198: 497-508. PMID 18438728 DOI: 10.1007/s00213-008-1141-8  1
2008 Padgett LW, Howlett AC, Shim JY. Binding mode prediction of conformationally restricted anandamide analogs within the CB1 receptor. Journal of Molecular Signaling. 3: 5. PMID 18302793 DOI: 10.1186/1750-2187-3-5  1
2008 Jones JD, Carney ST, Vrana KE, Norford DC, Howlett AC. Cannabinoid receptor-mediated translocation of NO-sensitive guanylyl cyclase and production of cyclic GMP in neuronal cells. Neuropharmacology. 54: 23-30. PMID 17707868 DOI: 10.1016/j.neuropharm.2007.06.027  1
2007 Niehaus JL, Liu Y, Wallis KT, Egertová M, Bhartur SG, Mukhopadhyay S, Shi S, He H, Selley DE, Howlett AC, Elphick MR, Lewis DL. CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a. Molecular Pharmacology. 72: 1557-66. PMID 17895407 DOI: 10.1124/mol.107.039263  1
2007 Anavi-Goffer S, Fleischer D, Hurst DP, Lynch DL, Barnett-Norris J, Shi S, Lewis DL, Mukhopadhyay S, Howlett AC, Reggio PH, Abood ME. Helix 8 Leu in the CB1 cannabinoid receptor contributes to selective signal transduction mechanisms. The Journal of Biological Chemistry. 282: 25100-13. PMID 17595161 DOI: 10.1074/jbc.M703388200  1
2007 Ward GR, Franklin SO, Gerald TM, Dempsey KT, Clodfelter DE, Krissinger DJ, Patel KM, Vrana KE, Howlett AC. Glucocorticoids plus opioids up-regulate genes that influence neuronal function. Cellular and Molecular Neurobiology. 27: 651-60. PMID 17554624 DOI: 10.1007/s10571-007-9151-3  1
2007 Grace CR, Cowsik SM, Shim JY, Welsh WJ, Howlett AC. Unique helical conformation of the fourth cytoplasmic loop of the CB1 cannabinoid receptor in a negatively charged environment. Journal of Structural Biology. 159: 359-68. PMID 17524664 DOI: 10.1016/j.jsb.2007.04.004  1
2007 Stephens-Hernandez AB, Livingston JN, Dacons-Brock K, Craft HL, Cameron A, Franklin SO, Howlett AC. Drama-based education to motivate participation in substance abuse prevention. Substance Abuse Treatment, Prevention, and Policy. 2: 11. PMID 17411423 DOI: 10.1186/1747-597X-2-11  1
2007 McCollum L, Howlett AC, Mukhopadhyay S. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells. The Journal of Pharmacology and Experimental Therapeutics. 321: 930-7. PMID 17379772 DOI: 10.1124/jpet.106.117549  1
2007 Awumey EM, Howlett AC, Putney JW, Diz DI, Bukoski RD. Ca(2+) mobilization through dorsal root ganglion Ca(2+)-sensing receptor stably expressed in HEK293 cells. American Journal of Physiology. Cell Physiology. 292: C1895-905. PMID 17267550 DOI: 10.1152/ajpcell.00404.2006  1
2006 Howlett AC, Mukhopadhyay S, Norford DC. Endocannabinoids and reactive nitrogen and oxygen species in neuropathologies. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 1: 305-16. PMID 18040807 DOI: 10.1007/s11481-006-9022-6  1
2006 Mukhopadhyay S, Das S, Williams EA, Moore D, Jones JD, Zahm DS, Ndengele MM, Lechner AJ, Howlett AC. Lipopolysaccharide and cyclic AMP regulation of CB(2) cannabinoid receptor levels in rat brain and mouse RAW 264.7 macrophages. Journal of Neuroimmunology. 181: 82-92. PMID 17045344 DOI: 10.1016/j.jneuroim.2006.08.002  1
2006 Shim JY, Howlett AC. WIN55212-2 docking to the CB1 cannabinoid receptor and multiple pathways for conformational induction. Journal of Chemical Information and Modeling. 46: 1286-300. PMID 16711748 DOI: 10.1021/ci0504824  1
2006 Gerald TM, Ward GR, Howlett AC, Franklin SO. CB1 knockout mice display significant changes in striatal opioid peptide and D4 dopamine receptor gene expression. Brain Research. 1093: 20-4. PMID 16684513 DOI: 10.1016/j.brainres.2006.03.088  1
2005 Howlett AC. Cannabinoid receptor signaling Handbook of Experimental Pharmacology. 168: 53-79. PMID 16596771 DOI: 10.1007/3-540-26573-2-2  1
2005 Awumey EM, Howlett AC, Diz DI. Is there a role for anandamide in cardiovascular regulation? Insights from studies of endocannabinoid metabolism. American Journal of Physiology. Heart and Circulatory Physiology. 289: H520-1. PMID 16014613 DOI: 10.1152/ajpheart.00433.2005  1
2005 Howlett AC. A short guide to the nomenclature of seven-transmembrane spanning receptors for lipid mediators. Life Sciences. 77: 1522-30. PMID 15953619 DOI: 10.1016/j.lfs.2005.05.003  1
2005 Mukhopadhyay S, Howlett AC. Chemically distinct ligands promote differential CB1 cannabinoid receptor-Gi protein interactions. Molecular Pharmacology. 67: 2016-24. PMID 15749995 DOI: 10.1124/mol.104.003558  1
2004 Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology. 47: 345-58. PMID 15464149 DOI: 10.1016/j.neuropharm.2004.07.030  1
2004 Howlett AC. Efficacy in CB1 receptor-mediated signal transduction. British Journal of Pharmacology. 142: 1209-18. PMID 15308578 DOI: 10.1038/sj.bjp.0705881  1
2003 Shim JY, Welsh WJ, Howlett AC. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction. Biopolymers. 71: 169-89. PMID 12767117 DOI: 10.1002/bip.10424  1
2002 Mukhopadhyay S, Shim JY, Assi AA, Norford D, Howlett AC. CB(1) cannabinoid receptor-G protein association: a possible mechanism for differential signaling. Chemistry and Physics of Lipids. 121: 91-109. PMID 12505694 DOI: 10.1016/S0009-3084(02)00153-6  1
2002 Howlett AC. The cannabinoid receptors. Prostaglandins & Other Lipid Mediators. 68: 619-31. PMID 12432948 DOI: 10.1016/S0090-6980(02)00060-6  1
2002 Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacological Reviews. 54: 161-202. PMID 12037135 DOI: 10.1124/pr.54.2.161  1
2002 Mukhopadhyay S, Chapnick BM, Howlett AC. Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. American Journal of Physiology. Heart and Circulatory Physiology. 282: H2046-54. PMID 12003810 DOI: 10.1152/ajpheart.00497.2001  1
2002 Shim JY, Welsh WJ, Cartier E, Edwards JL, Howlett AC. Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor. Journal of Medicinal Chemistry. 45: 1447-59. PMID 11906286 DOI: 10.1021/jm010267o  1
2002 Klein C, Sunahara RK, Hudson TY, Heyduk T, Howlett AC. Zinc inhibition of cAMP signaling. The Journal of Biological Chemistry. 277: 11859-65. PMID 11805091 DOI: 10.1074/jbc.M108808200  1
2001 Meschler JP, Howlett AC, Madras BK. Cannabinoid receptor agonist and antagonist effects on motor function in normal and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-treated non-human primates. Psychopharmacology. 156: 79-85. PMID 11465637 DOI: 10.1007/s002130100728  1
2001 Hudson TY, Corbett JA, Howlett AC, Klein C. Nitric oxide regulates adenylyl cyclase activity in rat striatal membranes Journal of Neurochemistry. 77: 1279-1284. PMID 11389178 DOI: 10.1046/j.1471-4159.2001.00331.x  1
2001 Meschler JP, Howlett AC. Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum. Neuropharmacology. 40: 918-26. PMID 11378162 DOI: 10.1016/S0028-3908(01)00012-0  1
2001 Mukhopadhyay S, Howlett AC. CB1 receptor-G protein association: Subtype selectivity is determined by distinct intracellular domains European Journal of Biochemistry. 268: 499-505. PMID 11168387 DOI: 10.1046/j.1432-1327.2001.01810.x  1
2000 Meschler JP, Conley TJ, Howlett AC. Cannabinoid and dopamine interaction in rodent brain: effects on locomotor activity. Pharmacology, Biochemistry, and Behavior. 67: 567-73. PMID 11164087 DOI: 10.1016/S0091-3057(00)00390-7  1
2000 Howlett AC, Mukhopadhyay S. Cellular signal transduction by anandamide and 2-arachidonoylglycerol Chemistry and Physics of Lipids. 108: 53-70. PMID 11106782 DOI: 10.1016/S0009-3084(00)00187-0  1
2000 Meschler JP, Kraichely DM, Wilken GH, Howlett AC. Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor. Biochemical Pharmacology. 60: 1315-23. PMID 11008125 DOI: 10.1016/S0006-2952(00)00447-0  1
2000 Berglund BA, Fleming PR, Rice KC, Shim JY, Welsh WJ, Howlett AC. Development of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2 cannabinoid receptor affinity and receptor activation. Drug Design and Discovery. 16: 281-94. PMID 10807034  1
2000 Howlett AC, Wilken GH, Pigg JJ, Houston DB, Lan R, Liu Q, Makriyannis A. Azido- and isothiocyanato-substituted aryl pyrazoles bind covalently to the CB1 cannabinoid receptor and impair signal transduction. Journal of Neurochemistry. 74: 2174-81. PMID 10800963 DOI: 10.1046/j.1471-4159.2000.0742174.x  1
2000 Meschler JP, Clarkson FA, Mathews PJ, Howlett AC, Madras BK. D(2), but not D(1) dopamine receptor agonists potentiate cannabinoid-induced sedation in nonhuman primates. The Journal of Pharmacology and Experimental Therapeutics. 292: 952-9. PMID 10688609  1
2000 Mukhopadhyay S, McIntosh HH, Houston DB, Howlett AC. The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain. Molecular Pharmacology. 57: 162-70. PMID 10617691  1
1999 Berglund BA, Boring DL, Howlett AC. Investigation of structural analogs of prostaglandin amides for binding to and activation of CB1 and CB2 cannabinoid receptors in rat brain and human tonsils. Advances in Experimental Medicine and Biology. 469: 527-33. PMID 10667378  1
1999 Howlett AC, Mukhopadhyay S, Shim JY, Welsh WJ. Signal transduction of eicosanoid CB1 receptor ligands Life Sciences. 65: 617-625. PMID 10462062 DOI: 10.1016/S0024-3205(99)00284-2  1
1999 Meschler JP, Howlett AC. Thujone exhibits low affinity for cannabinoid receptors but fails to evoke cannabimimetic responses. Pharmacology, Biochemistry, and Behavior. 62: 473-80. PMID 10080239 DOI: 10.1016/S0091-3057(98)00195-6  1
1999 Mukhopadhyay S, Cowsik SM, Lynn AM, Welsh WJ, Howlett AC. Regulation of G(i) by the CB1 cannabinoid receptor C-terminal juxtamembrane region: Structural requirements determined by peptide analysis Biochemistry. 38: 3447-3455. PMID 10079092 DOI: 10.1021/bi981767v  1
1999 Shim JY, Collantes ER, Welsh WJ, Howlett AC. Unified pharmacophoric model for cannabinoids and aminoalkylindoles derived from molecular superimposition of CB1 cannabinoid receptor agonists CP55244 and WIN55212-2 Acs Symposium Series. 719: 165-184.  1
1998 Howlett AC. The CB1 cannabinoid receptor in the brain Neurobiology of Disease. 5: 405-416. PMID 9974174 DOI: 10.1006/nbdi.1998.0215  1
1998 Ruh MF, Bi Y, Cox L, Berk D, Howlett AC, Bellone CJ. Effect of environmental estrogens on IL-1beta promoter activity in a macrophage cell line. Endocrine. 9: 207-11. PMID 9867255 DOI: 10.1385/ENDO:9:2:207  1
1998 Houston DB, Howlett AC. Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists. Cellular Signalling. 10: 667-74. PMID 9794249 DOI: 10.1016/S0898-6568(98)00013-8  1
1998 Berglund BA, Boring DL, Wilken GH, Makriyannis A, Howlett AC, Lin S. Structural requirements for arachidonylethanolamide interaction with CB1 and CB2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamide groups. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 59: 111-8. PMID 9774174 DOI: 10.1016/S0952-3278(98)90089-8  1
1998 Howlett AC, Song C, Berglund BA, Wilken GH, Pigg JJ. Characterization of CB1 cannabinoid receptors using receptor peptide fragments and site-directed antibodies. Molecular Pharmacology. 53: 504-10. PMID 9495818  1
1998 McIntosh HH, Song C, Howlett AC. CB1 cannabinoid receptor: cellular regulation and distribution in N18TG2 neuroblastoma cells. Brain Research. Molecular Brain Research. 53: 163-73. PMID 9473654 DOI: 10.1016/S0169-328X(97)00294-5  1
1997 Tao YP, Misko TP, Howlett AC, Klein C. Nitric oxide, an endogenous regulator of Dictyostelium discoideum differentiation Development. 124: 3587-3595. PMID 9342051  1
1997 Ruh MF, Taylor JA, Howlett AC, Welshons WV. Failure of cannabinoid compounds to stimulate estrogen receptors Biochemical Pharmacology. 53: 35-41. PMID 8960061 DOI: 10.1016/S0006-2952(96)00659-4  1
1996 Boring DL, Berglund BA, Howlett AC. Cerebrodiene, arachidonyl-ethanolamide, and hybrid structures: potential for interaction with brain cannabinoid receptors. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 55: 207-10. PMID 8931121 DOI: 10.1016/S0952-3278(96)90100-3  1
1996 Yamada K, Rice KC, Flippen-Anderson JL, Eissenstat MA, Ward SJ, Johnson MR, Howlett AC. (Aminoalkyl)indole isothiocyanates as potential electrophilic affinity ligands for the brain cannabinoid receptor. Journal of Medicinal Chemistry. 39: 1967-74. PMID 8642555 DOI: 10.1021/jm950932r  1
1995 Melvin LS, Milne GM, Johnson MR, Wilken GH, Howlett AC. Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity. Drug Design and Discovery. 13: 155-66. PMID 8872458  1
1995 Song C, Howlett AC. Rat brain cannabinoid receptors are N-linked glycosylated proteins Life Sciences. 56: 1983-1989. PMID 7776822 DOI: 10.1016/0024-3205(95)00179-A  1
1995 Belue RC, Howlett AC, Westlake TM, Hutchings DE. The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats Neurotoxicology and Teratology. 17: 25-30. PMID 7708016 DOI: 10.1016/0892-0362(94)00053-G  1
1995 Howlett AC. Pharmacology of cannabinoid receptors Annual Review of Pharmacology and Toxicology. 35: 607-634. PMID 7598509  1
1994 Evans DM, Lake JT, Johnson MR, Howlett AC. Endogenous cannabinoid receptor binding activity released from rat brain slices by depolarization Journal of Pharmacology and Experimental Therapeutics. 268: 1271-1277. PMID 8138940  1
1994 Koutek B, Prestwich GD, Howlett AC, Chin SA, Salehani D, Akhavan N, Deutsch DG. Inhibitors of arachidonoyl ethanolamide hydrolysis. The Journal of Biological Chemistry. 269: 22937-40. PMID 8083191  1
1994 Pinto JC, Potié F, Rice KC, Boring D, Johnson MR, Evans DM, Wilken GH, Cantrell CH, Howlett AC. Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid Molecular Pharmacology. 46: 516-522. PMID 7935333  1
1994 Westlake TM, Howlett AC, Bonner TI, Matsuda LA, Herkenham M. Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience. 63: 637-52. PMID 7898667 DOI: 10.1016/0306-4522(94)90511-8  1
1993 Houston DB, Howlett AC. Solubilization of the cannabinoid receptor from rat brain and its functional interaction with guanine nucleotide-binding proteins. Molecular Pharmacology. 43: 17-22. PMID 8423766  1
1993 Melvin LS, Milne GM, Johnson MR, Subramaniam B, Wilken GH, Howlett AC. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs. Molecular Pharmacology. 44: 1008-15. PMID 8246904  1
1993 Tao Y, Howlett AC, Klein C. Endogenous ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase that is not regulated by nitric oxide in Dictyostelium discoideum Cellular Signalling. 5: 763-775. PMID 7907497 DOI: 10.1016/0898-6568(93)90037-M  1
1992 Evans DM, Johnson MR, Howlett AC. Ca2+ ‐Dependent Release from Rat Brain of Cannabinoid Receptor Binding Activity Journal of Neurochemistry. 58: 780-782. PMID 1729420 DOI: 10.1111/j.1471-4159.1992.tb09787.x  1
1992 Houston DB, Howlett AC. Solubilization of the cannabinoid receptor from rat brain membranes. Annals of the New York Academy of Sciences. 654: 448-50. PMID 1632600  1
1992 Charalambous A, Yan G, Houston DB, Howlett AC, Compton DR, Martin BR, Makriyannis A. 5'-Azido-delta 8-THC: a novel photoaffinity label for the cannabinoid receptor. Journal of Medicinal Chemistry. 35: 3076-9. PMID 1323683  1
1991 Courtney ND, Howlett AC, Westfall TC. Regulation of nicotine-evoked dopamine release from PC12 cells. Life Sciences. 48: 1671-8. PMID 1850061 DOI: 10.1016/0024-3205(91)90127-W  1
1991 Courtney ND, Howlett AC, Westfall TC. Dopaminergic regulation of dopamine release from PC12 cells via a pertussis toxin-sensitive G protein. Neuroscience Letters. 122: 261-4. PMID 1827517 DOI: 10.1016/0304-3940(91)90873-R  1
1991 Howlett AC, Champion-Dorow TM, McMahon LL, Westlake TM. The cannabinoid receptor: biochemical and cellular properties in neuroblastoma cells. Pharmacology, Biochemistry, and Behavior. 40: 565-9. PMID 1806946 DOI: 10.1016/0091-3057(91)90364-8  1
1991 Wessels-Reiker M, Haycock JW, Howlett AC, Strong R. Vasoactive intestinal polypeptide induces tyrosine hydroxylase in PC12 cells Journal of Biological Chemistry. 266: 9347-9350. PMID 1674510  1
1991 O'Donnell KA, Howlett AC. Inhibition of adenylate cyclase by p-bromophenacyl bromide Biochemical Pharmacology. 42: 1941-1946. PMID 1660272 DOI: 10.1016/0006-2952(91)90593-T  1
1991 O'Donnell KA, Howlett AC. Muscarinic receptor binding is inhibited by quinacrine Neuroscience Letters. 127: 46-48. PMID 1652714 DOI: 10.1016/0304-3940(91)90891-V  1
1991 Westlake TM, Howlett AC, Ali SF, Paule MG, Scallet AC, Slikker W. Chronic exposure to delta 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors. Brain Research. 544: 145-9. PMID 1649662 DOI: 10.1016/0006-8993(91)90897-5  1
1990 Howlett AC. Reverse pharmacology applied to the cannabinoid receptor Trends in Pharmacological Sciences. 11: 395-397. PMID 2256177 DOI: 10.1016/0165-6147(90)90142-U  1
1990 Coezy ED, Corvol P, Howlett AC. Involvement of a pertussis toxin-sensitive G protein in the regulation of angiotensinogen production by an angiotensin II analog in HepG2 cells Cellular Signalling. 2: 67-76. PMID 2176801 DOI: 10.1016/0898-6568(90)90034-8  1
1990 Howlett AC, Johnson MR, Melvin LS. Classical and nonclassical cannabinoids: mechanism of action--brain binding Nida Research Monograph. 96: 100-111. PMID 2172821  1
1990 Bidaut‐Russell M, Devane WA, Howlett AC. Cannabinoid Receptors and Modulation of Cyclic AMP Accumulation in the Rat Brain Journal of Neurochemistry. 55: 21-26. PMID 2162376 DOI: 10.1111/j.1471-4159.1990.tb08815.x  1
1990 Howlett AC, Champion TM, Wilken GH, Mechoulam R. Stereochemical effects of 11-OH-Δ8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor Neuropharmacology. 29: 161-165. PMID 2158635 DOI: 10.1016/0028-3908(90)90056-W  1
1990 Howlett AC, Bidaut-Russell M, Devane WA, Melvin LS, Johnson MR, Herkenham M. The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends in Neurosciences. 13: 420-3. PMID 1700516 DOI: 10.1016/0166-2236(90)90124-S  1
1990 Howlett AC, Bidaut-Russell M, Champion-Dorow T, Devane WA, Westlake TM, Wilken GH, Melvin LS, Johnson MR. Cannabinoid receptors in the brain and cultured neuroblastoma cells European Journal of Pharmacology. 183: 2149-2150. DOI: 10.1016/0014-2999(90)93673-E  1
1989 Howlett AC, Scott DK, Wilken GH. Regulation of adenylate cyclase by cannabinoid drugs. Insights based on thermodynamic studies Biochemical Pharmacology. 38: 3297-3304. PMID 2554920 DOI: 10.1016/0006-2952(89)90628-X  1
1988 Howlett AC, Johnson MR, Melvin LS, Milne GM. Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model. Molecular Pharmacology. 33: 297-302. PMID 3352594  1
1988 Dill JA, Howlett AC. Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs Journal of Pharmacology and Experimental Therapeutics. 244: 1157-1163. PMID 2855242  1
1988 Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of a cannabinoid receptor in rat brain. Molecular Pharmacology. 34: 605-13. PMID 2848184  1
1988 Beinfeld MC, Brick PL, Howlett AC, Holt IL, Pruss RM, Moskal JR, Eiden LE. The regulation of vasoactive intestinal peptide synthesis in neuroblastoma and chromaffin cells. Annals of the New York Academy of Sciences. 527: 68-76. PMID 2839090  1
1987 Howlett AC. Cannabinoid inhibition of adenylate cyclase: Relative activity of constituents and metabolites of marihuana Neuropharmacology. 26: 507-512. PMID 3601007 DOI: 10.1016/0028-3908(87)90035-9  1
1987 Walz MA, Holt IL, Howlett AC. Cyclic nucleotide phosphodiesterase isozymes in neuroblastoma cells Journal of Neuroscience Research. 17: 291-297. PMID 3037096  1
1987 Walz MA, Howlett AC. Thyroid effects on adenosine 3',5'-monophosphate levels and adenylate cyclase in cultured neuroblastoma cells Endocrinology. 120: 1265-1271. PMID 3030693  1
1987 Howlett AC. Regulation of adenylate cyclase in a cultured neuronal cell line by marijuana constituents, metabolites of delta-9-tetrahydrocannabinol, and synthetic analogs having psychoactivity Nida Research Monograph. 79: 148-157. PMID 2830535  1
1987 Bidaut-Russell M, Howlett AC. Muscarinic pharmacology of the inhibition of adenylate cyclase in N18TG2 neuroblastoma cells Neurochemistry International. 11: 287-292. DOI: 10.1016/0197-0186(87)90048-9  1
1986 Devane WA, Spain JW, Coscia CJ, Howlett AC. An assessment of the role of opioid receptors in the response to cannabimimetic drugs. Journal of Neurochemistry. 46: 1929-35. PMID 3009717 DOI: 10.1111/j.1471-4159.1986.tb08515.x  1
1986 Howlett AC, Qualy JM, Khachatrian LL. Involvement of G(i) in the inhibition of adenylate cyclase by cannabimimetic drugs Molecular Pharmacology. 29: 307-313. PMID 2869405  1
1985 Brick PL, Howlett AC, Beinfeld MC. Synthesis and release of vasoactive intestinal polypeptide (VIP) by mouse neuroblastoma cells: modulation by cyclic nucleotides and ascorbic acid. Peptides. 6: 1075-8. PMID 3010255 DOI: 10.1016/0196-9781(85)90430-9  1
1985 Howlett AC. Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes Molecular Pharmacology. 27: 429-436. PMID 2984538  1
1985 Walz MA, Howlett AC. Cyclic AMP levels are increased in neuroblastoma cells grown in presence of thyroid hormone Federation Proceedings. 44.  1
1984 Roth BL, Beinfeld MC, Howlett AC. Secretin Receptors on Neuroblastoma Cell Membranes: Characterization of 125I‐Labeled Secretin Binding and Association with Adenylate Cyclase Journal of Neurochemistry. 42: 1145-1152. PMID 6321661 DOI: 10.1111/j.1471-4159.1984.tb12723.x  1
1984 Howlett AC, Fleming RM. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membrane Molecular Pharmacology. 26: 532-538. PMID 6092901  1
1984 Howlett AC. Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds Life Sciences. 35: 1803-1810. PMID 6090851 DOI: 10.1016/0024-3205(84)90278-9  1
1982 Howlett AC. Effects of NaCl concentration on adenylate cyclase regulation by prostaglandins and guanine nucleotides Journal of Cyclic Nucleotide Research. 8: 91-102. PMID 6757290  1
1982 Howlett AC. Stimulation of neuroblastoma adenylate cyclase by arachidonic acid metabolites Molecular Pharmacology. 21: 664-670. PMID 6287201  1
1981 Howlett AC. Prostacyclin-stimulated adenylate cyclase in neuroblastoma cells Pharmacologist. 23.  1
1980 Howlett AC, Gilman AG. Hydrodynamic properties of the regulatory component of adenylate cyclase Journal of Biological Chemistry. 255: 2861-2866. PMID 6244297  1
1979 Ross EM, Howlett AC, Gilman AG. Identification and partial characterization of some components of hormone-stimulated adenylate cyclase. Progress in Clinical and Biological Research. 31: 735-49. PMID 231786  1
1979 Howlett AC, Sternweis PC, Macik BA, Van Arsdale PM, Gilman AG. Reconstitution of catecholamine-sensitive adenylate cyclase. Association of a regulatory component of the enzyme with membranes containing the catalytic protein and β-adrenergic receptors Journal of Biological Chemistry. 254: 2287-2295. PMID 218930  1
1978 Burgess WH, Howlett AC, Kretsinger RH, Gilman AG. S49 lymphoma wild type and variant clones contain normal calcium dependent regulator Journal of Cyclic Nucleotide Research. 4: 175-181. PMID 214461  1
1978 Howlett AC, Van Arsdale PM, Gilman AG. Efficiency of coupling between the beta adrenergic receptor and adenylate cyclase Molecular Pharmacology. 14: 531-539. PMID 210367  1
1978 Ross EM, Howlett AC, Ferguson KM, Gilman AG. Reconstitution of hormone-sensitive adenylate cyclase activity with resolved components of the enzyme. The Journal of Biological Chemistry. 253: 6401-12. PMID 210183  1
1978 Ross EM, Haga T, Howlett AC, Schwarzmeier J, Schleifer LS, Gilman AG. Hormone-sensitive adenylate cyclase: resolution and reconstitution of some components necessary for regulation of the enzyme. Advances in Cyclic Nucleotide Research. 9: 53-68. PMID 208395  1
Show low-probability matches.